TCR2 Therapeutics Inc.
Hedge Funds Holdings
Last updated:
TCR2 Therapeutics Inc.‘s stocks are currently a part of 40 hedge funds’ portfolios, which represents 31.82% of the total amount of its stocks outstanding. This makes up a total of 12.29M shares of TCR2 Therapeutics Inc.. Compared to the previous quarter, the number fell by -41.95% or -8.88M shares fewer. As for the holding position changes, 17.5% (7) of current hedge fund investors increased the number of shares held, 30% (12) of current holders sold a part of the shares held, and 7.5% (3) closed the holdings completely. 7 hedge funds are new holders of TCR2 Therapeutics Inc. stock in Q1 2023, it is 17.5% of total holders.
Hedge funds holding TCR2 Therapeutics (Q1 2019 – Q1 2023)
| Q1 2019 | 24 |
|---|---|
| Q2 2019 | 32 |
| Q3 2019 | 40 |
| Q4 2019 | 45 |
| Q1 2020 | 49 |
| Q2 2020 | 63 |
| Q3 2020 | 82 |
| Q4 2020 | 118 |
| Q1 2021 | 127 |
| Q2 2021 | 117 |
| Q3 2021 | 110 |
| Q4 2021 | 116 |
| Q1 2022 | 85 |
| Q2 2022 | 73 |
| Q3 2022 | 73 |
| Q4 2022 | 59 |
| Q1 2023 | 40 |
Hedge funds changes in TCR2 Therapeutics positions (Q1 2019 – Q1 2023)
| Q1 2019 | 24 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 14 | 5 | 8 | 6 | -1 |
| Q3 2019 | 12 | 21 | 6 | 3 | -2 |
| Q4 2019 | 8 | 27 | 4 | 3 | 3 |
| Q1 2020 | 8 | 17 | 14 | 4 | 6 |
| Q2 2020 | 18 | 26 | 12 | 4 | 3 |
| Q3 2020 | 25 | 35 | 12 | 6 | 4 |
| Q4 2020 | 44 | 42 | 18 | 8 | 6 |
| Q1 2021 | 23 | 60 | 29 | 14 | 1 |
| Q2 2021 | 12 | 49 | 34 | 22 | 0 |
| Q3 2021 | 17 | 40 | 34 | 24 | -5 |
| Q4 2021 | 38 | 33 | 35 | 30 | -20 |
| Q1 2022 | 12 | 23 | 34 | 42 | -26 |
| Q2 2022 | 14 | 9 | 34 | 24 | -8 |
| Q3 2022 | 10 | 16 | 28 | 11 | 8 |
| Q4 2022 | 8 | 15 | 23 | 22 | -9 |
| Q1 2023 | 7 | 7 | 12 | 3 | 11 |
Hedge funds changes in TCR2 Therapeutics stock options (Q1 2019 – Q1 2023)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 109,000 |
| Q2 2020 | 633,000 | 0 |
| Q3 2020 | 708,000 | 1,473,000 |
| Q4 2020 | 3,794,000 | 3,594,000 |
| Q1 2021 | 1,923,000 | 2,668,000 |
| Q2 2021 | 1,461,000 | 6,058,000 |
| Q3 2021 | 1,299,000 | 4,137,000 |
| Q4 2021 | 123,000 | 288,000 |
| Q1 2022 | 7,000 | 69,000 |
| Q2 2022 | 1,941,000 | 605,000 |
| Q3 2022 | 1,141,000 | 429,000 |
| Q4 2022 | 544,506 | 187,157 |
| Q1 2023 | 29,700,000 | 0 |